• BFH772 (VEGFR2 inhibitor): Technical Use and Protocol Parame

  2026-06-03

  BFH772 is a potent, highly selective VEGFR2 inhibitor intended for precise inhibition of VEGFR2-mediated angiogenesis, especially in tumor model research. It should not be used where water solubility or broad-spectrum kinase inhibition are required, but is valuable where selectivity and organic solvent compatibility are essential.

• Biomimetic Hydrogel Microspheres for Responsive OA Therapy

  2026-06-03

  This study introduces a biomimetic dual-network hydrogel microsphere designed for targeted, responsive drug delivery and cartilage protection in progressive osteoarthritis. The platform leverages environmental cues, such as pH and reactive oxygen species, to regulate drug release and tissue protection, offering a promising approach to address OA’s complex pathology.

• MRT68921: ULK1/2 Inhibition Unveils Autophagy-Lipid Metaboli

  2026-06-02

  Explore how MRT68921, a potent ULK1 kinase inhibitor, uniquely advances autophagy inhibition and lipid metabolism research. Discover novel assay insights and protocol parameters grounded in the latest scientific findings.

• Nelfinavir Mesylate: Advanced HIV-1 Protease Inhibitor Workf

  2026-06-02

  Nelfinavir Mesylate is redefining both HIV infection research and ferroptosis modulation with its dual action as a potent HIV-1 protease inhibitor and DDI2 pathway modulator. This guide delivers actionable workflows, troubleshooting insights, and cross-domain strategies to maximize experimental success and translational impact.

• Resazurin Sodium Salt: Fluorogenic Indicator for Cell Viabil

  2026-06-01

  Resazurin sodium salt delivers robust, high-sensitivity detection of cell viability and metabolic activity, standing out as a versatile fluorogenic oxidation-reduction indicator for modern experimental workflows. Its rapid, non-destructive readout and compatibility with high-throughput platforms empower researchers to confidently assess proliferation and cytotoxicity, even in demanding cancer and metabolic models.

• GW4064 in FXR/TLR4 Pathway Research: New Frontiers in Liver

  2026-06-01

  Explore how GW4064, a non-steroidal FXR agonist, enables advanced modeling of the FXR/TLR4/ferroptosis axis in liver fibrosis. This article offers unique protocol insights and practical strategies for leveraging GW4064 in complex metabolic and fibrotic research.

• Prednisolone in Glucocorticoid Signaling: Mechanistic Insigh

  2026-05-31

  Explore how Prednisolone, a synthetic glucocorticoid, advances mechanistic glucocorticoid signaling research and assay development. This article delivers deep analysis on integrating targeted protein degradation innovations with classic corticosteroid applications.

• Hoechst 33258: Precision Bis-Benzimide DNA Stain for Tumor p

  2026-05-30

  Hoechst 33258 empowers researchers to visualize DNA with remarkable clarity in both live and fixed cells, a capability crucial for dissecting tumor pH dynamics in advanced chemo-immunotherapy studies. This article translates recent breakthroughs into optimized workflows and actionable troubleshooting for enhanced data quality and reproducibility.

• Applied Cancer Assays with Anti-ROR1 Antibody (Zilovertamab)

  2026-05-29

  Leverage Anti-ROR1 Antibody (Zilovertamab) for precise inhibition of Wnt5a-induced ROR1 signaling in functional cancer research. This guide details advanced workflow strategies, troubleshooting tactics, and practical insights that set APExBIO’s reagent apart for ELISA, FACS, and animal model applications.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma

  2026-05-29

  This study demonstrates that inhibiting DOT1L, an epigenetic regulator, reprograms innate immunity in multiple myeloma (MM) cells and significantly enhances the anti-myeloma efficacy of lenalidomide. By uncovering the interplay between DOT1L inhibition and immunomodulatory drug responses, the research highlights a promising avenue for optimizing MM therapy with combined epigenetic and immune system modulation.

• Peroxynitrite-Driven Necroptosis in Cardiac I/R with Hyperho

  2026-05-28

  Liu et al. (2025) identify a novel ER stress–mediated Ca2+ flux pathway, regulated by peroxynitrite, that drives necroptosis in cardiac microvascular endothelial cells during ischemia–reperfusion injury with hyperhomocysteinemia. This mechanistic insight highlights IP3R-dependent Ca2+ transfer as a therapeutic target for microvascular injury in acute cardiovascular events.

• HyperScribe SP6 High Yield RNA Synthesis Kit: Advancing In V

  2026-05-28

  The HyperScribe SP6 High Yield RNA Synthesis Kit streamlines high-yield, customizable RNA production for cutting-edge applications in vaccine research, immune pathway dissection, and probe synthesis. Its robust protocol flexibility enables seamless capped and biotinylated RNA synthesis, giving researchers a decisive edge across diverse experimental needs.

• Dabigatran (Pradaxa): Evidence, Mechanism, and Research Use

  2026-05-27

  Dabigatran (Pradaxa) is a potent, reversible direct thrombin inhibitor used in anticoagulation research and clinical stroke prevention. Its well-characterized mechanism targets both free and fibrin-bound thrombin. Defined IC50 values and robust reversal protocols make it a benchmark for coagulation function testing.

• Losmapimod (GW856553X): Optimizing Inflammation Research Wor

  2026-05-27

  Losmapimod (GW856553X) drives precision in inflammation signaling modulation and vascular function research, enabling robust, reproducible results in hypertension and COPD models. Recent structural insights reveal dual-action inhibition, offering researchers new strategies to enhance assay specificity and potency.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Amplifying Fluoresce

  2026-05-26

  The Cy5 Goat Anti-Mouse IgG (H+L) Antibody delivers robust, high-sensitivity fluorescent detection across immunohistochemistry, immunocytochemistry, and flow cytometry workflows. Its precision amplification and versatility empower researchers to surmount complex assay challenges, especially in advanced vaccine and protein particle research.

14617 records 1/975 page Next 12345 下5页 Last page